← Open Payments lookup

SUSAN CUCCIARDI: Open Payments

NPI 1528271467 · SILVERDALE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,388 in 71 payments from 19 companies in 2025. Trend: 2023 $1,393 · 2024 $1,645 · 2025 $1,388

Food & beverage: $1,388
CompanyPaymentsAmount
GENZYME CORPORATION15$312
GlaxoSmithKline, LLC.19$288
AstraZeneca Pharmaceuticals LP12$256
Grifols USA, LLC4$102
Regeneron Healthcare Solutions, Inc.3$56
Insmed, Inc.2$43
PFIZER INC.2$43
Amgen Inc.2$42
Vifor Pharma, Inc.2$37
Merck Sharp & Dohme LLC1$34

Products named: DUPIXENT, TRELEGY ELLIPTA, NUCALA, TEZSPIRE, Prolastin-C Liquid, FASENRA, AIRSUPRA, Arikayce.

Industry payments across WA — which companies pay providers there.